Counterfeiting is no longer a back-alley problem. It is an industrialized global trade estimated at 467 billion dollars a year, according to the OECD and the EU Intellectual Property Office.[1] The fakes are better made, the routes to market are more sophisticated, and the packaging that once signaled "this is real" is easier than ever to imitate.

At the same time, regulators are rewriting what a package has to do. Between the EU Digital Product Passport, the GS1 move to 2D barcodes, and pharmaceutical serialization rules already in force, packaging is shifting from a passive wrapper into a connected, verifiable data carrier. This guide maps the anti-counterfeit packaging technologies available in 2026, what each one is good at, where each one fails, and how to combine them into a defense that actually holds.

‍

What is anti-counterfeit packaging?

Anti-counterfeit packaging is any combination of materials, markings, and digital technology added to a product or its packaging to make imitation harder and authenticity verifiable. It spans three broad families: overt features a person can see, covert features hidden from the naked eye, and digital or connected features that link the physical item to a secure online record.

The strongest programs use more than one. A hologram deters a casual copier, while a cryptographic chip defeats a sophisticated one. The aim is layered friction, so that defeating the package costs more than the counterfeit is worth.

‍

Why it matters more in 2026

Three regulatory currents are moving brands from optional protection toward mandatory traceability.

The first is the EU Digital Product Passport (DPP), introduced under the Ecodesign for Sustainable Products Regulation. It is arriving product group by product group. The first legally binding version, the battery passport, becomes mandatory on 18 February 2027, with textiles, furniture, electronics, and other consumer categories following later this decade through the ESPR Working Plan.[2] Each passport links to the physical item through a data carrier, typically a QR code or an NFC or RFID chip. Pharmaceuticals are excluded from the ESPR framework under Article 1(2) and follow their own rules.

The second is GS1 Sunrise 2027. Retail point-of-sale systems are expected to read 2D barcodes, such as QR codes carrying a GS1 Digital Link, by the end of 2027.[3] That puts a scannable code on nearly every product, which is useful for information but proves little about authenticity on its own.

The third is already live in pharma. EU prescription packs have carried a 2D DataMatrix unique identifier and a tamper-evident feature since 2019 under the Falsified Medicines Directive,[4] and the US Drug Supply Chain Security Act now requires interoperable, item-level traceability.

The common thread is simple: a code is going on the pack no matter what. The open question is whether that code can be trusted.

👉 Related reading: Digital Product Passport: What It Is and How Brands Prepare. What the DPP is, which product groups it covers, and how a single connected label can satisfy the passport requirement while doing double duty for brand protection.

‍

The main anti-counterfeit technologies

Overt features. Holograms, color-shift inks, security foils, and visible seals need no tools to check. They build consumer confidence and deter opportunistic copying. Their weakness is well known: sophisticated counterfeiters now reproduce holograms and foils convincingly, and a shopper cannot tell a good fake from the real thing.

Covert features. Microtext, invisible UV or infrared inks, chemical taggants, and forensic markers are hidden and usually need a special reader or a lab to verify. They are excellent for investigators and customs and hard to copy without knowing they exist. The trade-off is that ordinary buyers and retailers cannot use them, so they help after the fact rather than at the point of sale.

Serialization and track-and-trace. Serialization gives each item a unique identity, usually encoded in a QR code or GS1 DataMatrix, and logs it through the supply chain. This is the backbone of pharma compliance and the foundation of the DPP. It answers "where has this been," but a printed code, on its own, can be photographed and cloned onto fakes.

Tamper-evident packaging. Breakable seals, void labels, and frangible closures reveal whether a package has been opened. They protect integrity rather than identity, and they are strongest when paired with a digital layer that can register and report the breach.

Digital and connected features. RFID and NFC smart labels embed a chip in the label or seal. Unlike a printed mark, the chip carries a cryptographic identity that cannot be reproduced by copying an image. A shopper taps the pack with a phone, no app required, and the item is verified in real time. Dual-frequency labels add UHF RFID for warehouse-scale reads, so one tag serves both consumer authentication and supply-chain visibility.

👉 Related reading: How NFC Works for Product Authentication. The mechanics behind tap-to-verify: what actually happens in the moment a phone touches an NFC label and returns a genuine-or-fake verdict, explained without the jargon.

‍

The layers, side by side

‍

No single layer is enough

The mistake most programs make is betting on one technology. Overt features reassure but can be faked. Covert features are secure but invisible to buyers. Printed codes enable traceability but copy easily. Each one solves part of the problem and leaves the rest open.

A resilient 2026 program layers them: an overt cue for confidence, a covert or forensic marker for investigators, serialization for traceability, tamper evidence for integrity, and a connected chip that ties them together with authentication a buyer can perform in seconds.

👉 Related reading: QR Code vs NFC for Brand Protection. A head-to-head on the two most common data carriers, where each one wins, where a printed code falls short, and why the smartest programs use both together.

‍

How to choose

Match the defense to the risk.

For high-risk regulated goods such as pharmaceuticals and medical products, serialization plus tamper evidence plus cryptographic authentication is becoming the baseline rather than the ceiling. For premium consumer goods such as spirits, cosmetics, and luxury, connected NFC delivers authentication and engagement, with tamper evidence to catch refill fraud. For broad consumer categories entering DPP scope, a GS1 2D code covers compliance and reach, upgraded with a chip wherever authenticity and engagement carry real commercial value.

👉 Related reading: Product Authentication and Anti-Counterfeiting for Pharmaceuticals. How serialization, tamper evidence, and cryptographic authentication combine to protect regulated medicines from factory to patient, and where the biggest gaps still sit.

👉 Related reading: NFC Authentication for the Wine and Spirits Industry. How premium drinks brands verify each bottle, catch refill fraud, and turn authentication into storytelling, all from the label already on the glass.

‍

From protection to connection

The most useful shift in 2026 is recognizing that anti-counterfeit packaging no longer has to be a pure cost center. A connected label that proves authenticity can also deliver product information, register ownership, carry a Digital Product Passport, and open a direct channel to the buyer. Protection becomes connection, and connection becomes data.

That is the logic behind ForgeStop's InfoTap® smart labels and BatchMaker™ encoding: one chip that authenticates the item, carries its regulated information, and turns every scan into first-party insight. Protect, connect, experience, from a single tap.

If you are deciding which layers your product actually needs, or how to make one label satisfy both a regulator and a marketer, talk to ForgeStop.

‍

Sources

1. OECD and EUIPO, global trade in counterfeit and pirated goods estimated at USD 467 billion (2021 customs seizure data). 2. Ecodesign for Sustainable Products Regulation, Regulation (EU) 2024/1781; battery passport mandatory from 18 February 2027 under the EU Battery Regulation (EU) 2023/1542; further product groups phased in via the ESPR Working Plan 2025-2030; pharmaceuticals excluded under ESPR Article 1(2). 3. GS1, 2D barcodes at retail point-of-sale (Sunrise 2027): retail POS systems expected to read QR codes carrying a GS1 Digital Link and GS1 DataMatrix codes by 31 December 2027. 4. Commission Delegated Regulation (EU) 2016/161, supplementing the EU Falsified Medicines Directive (2011/62/EU); safety features mandatory on most prescription packs since 9 February 2019.